MedMira Inc.
MIR
Rank in Stocks
#25237
MedMira Inc. is a biotechnology company focused on the research, development,... MedMira Inc. is a biotechnology company focused on the research, development, manufacturing, and global commercialization of rapid diagnostic solutions and related technology platforms. Its operations span North America, Europe, the Asia Pacific region, and other international markets. MedMira offers a diverse portfolio of rapid diagnostic tests and technology platforms. Its diagnostic solutions include Reveal HIV, which identifies HIV-1 and HIV-2 antibodies in various blood samples; Reveal TP, a rapid test for syphilis antibodies (Treponema pallidum); and Reveal HP, designed to detect Helicobacter pylori antibodies. The company also provides Multiplo, a line of multiplex tests for combined screening of conditions such as HIV-1/2, Hepatitis B and C, and syphilis, as well as the Miriad triple product for initial HIV and hepatitis screening. In the realm of respiratory and viral diagnostics, MedMira developed VYRA CoV2 for SARS-CoV-2 nucleocapsid antigen detection, VYRA CoV2Flu for simultaneous antigen testing of SARS-CoV-2, Influenza A, and Influenza B, and REVEALCOVID-19, an antibody test for COVID-19. Beyond diagnostic kits, MedMira provides the Miriad RVF toolkit, a platform that facilitates the development and market entry of rapid diagnostics. MedMira distributes its offerings through a wide network of medical distributors and strategic partners. Its customer base is broad, serving various segments of the healthcare industry, including clinical laboratories, hospitals, point-of-care clinics, government agencies, humanitarian aid groups, and public health bodies. The company was established in 1993, is headquartered in Halifax, Canada, and operates as a subsidiary of MedMira Holding AG.
Share Price
$0.03894798
Last synced: 2026-11-10
Market Cap
$27.17M
Change (1 day)
10.00%
Change (1 year)
-27.25%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade MedMira Inc. (MIR)
Category
Healthcare
Operating Margin for MedMira Inc. (MIR)
Operating Margin as of November 2026 TTM: -473.40%
According to MedMira Inc.'s latest financial reports, its current operating margin (TTM) is -473.40%. At the end of 2025 the company had an operating margin of -1,492.56%.
Operating Margin history for MedMira Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -473.40% | -68.28% |
| 2025 | -1,492.56% | 139.33% |
| 2024 | -623.65% | 38.74% |
| 2023 | -449.52% | 194.52% |
| 2022 | -152.63% | 1,676.83% |
| 2021 | -8.59% | -93.93% |
| 2020 | -141.46% | -42.43% |
| 2019 | -245.72% | -21.37% |
| 2018 | -312.51% | 9.49% |
| 2017 | -285.43% | 43.82% |
| 2016 | -198.46% | 225.40% |
| 2015 | -60.99% | -56.79% |
| 2014 | -141.15% | 30.46% |
| 2013 | -108.19% | -51.39% |
| 2012 | -222.58% | 9.05% |
| 2011 | -204.11% | -6.28% |
| 2010 | -217.79% | -1.94% |
| 2009 | -222.10% | 4.23% |
| 2008 | -213.09% | 1.78% |
| 2007 | -209.37% | -20.07% |
| 2006 | -261.95% | 56.72% |
| 2005 | -167.15% | 16.66% |
| 2004 | -143.28% | -60.90% |
| 2003 | -366.40% | -91.78% |
| 2002 | -4,459.52% | 148.71% |
| 2001 | -1,793.05% | -57.47% |
| 2000 | -4,216.38% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.08% |
US
|
|
| -149.01% | -99.69% |
US
|
|
| 25.57% | -100.05% |
AU
|
|
| 31.23% | -100.07% |
BE
|
|
| 29.35% | -100.06% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about MedMira Inc.'s operating margin
What is MedMira Inc.'s operating margin?
MedMira Inc.'s operating margin is -473.40%, as of Nov 2026.
What was MedMira Inc.'s operating margin in 2025?
In 2025, MedMira Inc.'s operating margin was -1,492.56%, compared with -623.65% in 2024.
How has MedMira Inc.'s operating margin changed since 2020?
From 2020 to 2025, MedMira Inc.'s operating margin was highest in 2021 (-8.59%) and lowest in 2025 (-1,492.56%).
How does MedMira Inc.'s operating margin compare with similar companies?
MedMira Inc.'s operating margin (-473.40%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.